Posts in tag
SGLT2 inhibitors
Empagliflozin PBS population expanded
Eligible patients more than doubled in line with largest trial on SGLT-2 inhibitors in CKD The PBS listing of Jardiance (empagliflozin 10mg) will be significantly expanded to include a broader …
Oral versions of GLP-1s on the horizon
With benefits beyond glucose control for the “new kid on the block” in diabetes management, leading researcher foreshadows oral versions with less side effects New versions of GLP-1 receptor agonists …
Diabetes med cardio boost
A multinational study involving Australian researchers has found more evidence for cardiovascular benefits associated with the newest group of oral medications used to treat type 2 diabetes New research has …